| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 385 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 1.722 | 2.503 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -1.337 | -2.503 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -1.337 | -2.503 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Q Med Publishing S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 31.933 | 29.500 | 29.000 | 28.468 | 28.971 | 28.421 | 27.791 | 27.877 | 27.793 | 27.637 |
| Inventories | 22.220 | 21.993 | 21.621 | 21.224 | 20.813 | 20.419 | 19.966 | 20.028 | 19.967 | 19.855 |
| Receivables | 9.707 | 7.500 | 7.373 | 7.238 | 7.077 | 6.943 | 6.789 | 6.810 | 6.789 | 6.751 |
| Cash | 6 | 6 | 6 | 6 | 1.081 | 1.060 | 1.037 | 1.040 | 1.037 | 1.031 |
| Shareholders Funds | -34.387 | -36.540 | -35.921 | -35.262 | -34.579 | -33.924 | -33.172 | -33.274 | -33.174 | -32.988 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 66.320 | 66.043 | 64.926 | 63.734 | 63.554 | 62.349 | 60.966 | 61.155 | 60.970 | 60.629 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5814 - 5814" | |||||||||
| CAEN Financial Year |
5814
|
|||||||||
Comments - Q Med Publishing S.r.l.